Cite
HARVARD Citation
Bo Kunkel, J. et al. (n.d.). Low-dose dobutamine infusion and single-dose tocilizumab in acute myocardial infarction patients with high risk of cardiogenic shock development - rationale and design of the DOBERMANN trial. European heart journal. p. . [Online].